NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT00627666 2013-03-26Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological CancerNational Cancer Institute (NCI)Phase 2 Completed52 enrolled
NCT00005641 2012-12-11Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow TransplantationH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Terminated